Search
Cell therapy has shown remarkable clinical success but involves complex and labor-intensive manufacturing process steps. Our cell therapy manufacturing solutions help streamline every step of the manufacturing process, reducing variability and enhancing the quality of cell therapies.
From cell isolation to expansion, final formulation, and analytical solutions, our cell therapy manufacturing solutions facilitate unit operation automation that are designed to perform with exceptional accuracy and reliability. These instruments are compatible with the CTS portfolio of cell therapy products that are cGMP manufactured, safety tested, backed by regulatory documentation, and supported globally by field-based experts.
Modular automation and simplicity designed with your needs in mind, offering:
- Lower contamination risk—closed, automated processes reduce manual handling and microbial exposure.
- Consistent quality—standardized workflows ensure batch-to-batch reliability and regulatory compliance.
- Flexible and scalable—easily integrate superior tools and scale as your needs grow, without system overhauls.
- Cost-efficient—minimize labor, errors, and cleanroom costs while maximizing capital efficiency.
- Space-saving design—compact modules reduce cleanroom footprint and maintenance burden.
- Real-time control—digital integration helps enable live instrument monitoring, traceability, and process optimization of workflows.
Discover cell therapy process development and GMP manufacturing solutions
Explore our GMP-manufactured products—designed to support your cell therapy workflow needs from discovery through clinical and commercial manufacturing.
Together with our GMP-compliant, closed automated and modular manufacturing solutions we offer supporting consumables, media, cytokines, and software products that help enable GMP-compliant cell therapy production.
Accelerating cell therapy manufacturing workflows with modular automation
Discover the latest advancements in automation and innovative manufacturing processes to accelerate cell therapy commercialization. Hear from specialists as they share insights, challenges, and successes in implementing flexible, scalable, and automated solutions.
Next-level automation
Learn how Thermo Fisher Scientific is transforming cell therapy manufacturing through advanced gene-level automation, with insights from leading industry experts.
Leveraging flexibility and automation in next-gen cell therapy manufacturing
Watch this on-demand webinar to learn how next-gen cell therapy manufacturing leverages flexibility and automation to address capacity challenges and enhance global patient access to advanced treatments.
Process optimization in cell therapy workflows is crucial for establishing robust, repeatable, and cost-effective manufacturing processes that help ensure consistent product quality, safety, and efficacy. It addresses challenges such as variability in patient-derived cells, manual and open operations that risk contamination, and difficulties scaling from clinical to commercial production while meeting stringent regulatory requirements.
Address cell therapy manufacturing challenges with our automated, closed modular instruments and cGMP-compliant Gibco CTS media and reagents, including PeproGMP cytokines to meet your cell specific workflow needs.
Optimize your cell therapy manufacturing with Thermo Fisher Scientific
- Closed automated processes—help ensure safety and sterility.
- Efficient and scalable—seamlessly transition from preclinical to clinical phases.
- Digital integration—CFR Part 21 compliant software solutions for seamless instrument connectivity.
- Flexible and adaptable—accommodate various cell therapy protocols with ease.
Optimize your cell therapy workflows
Automated Cell Therapy manufacturing solutions
- CTS Rotea Counter Flow Centrifugation system
- CTS Xenon Electroporation System
- CTS DynaCellect Magnetic Separation System
- CTS Compleo Fill and Finish System (coming soon)
- Advanced CO2 incubators for cell therapy
Cell therapy process development solutions
Product characterization is crucial in cell therapy manufacturing to help ensure innovative therapies reach patients safely. Analytical testing of cell therapies faces challenges due to the complexity and variability of living cell products, limited sample availability, and the need for rapid safety testing. Conventional assays often involve complex manual steps, longer turnaround times, and lack standardization. At Thermo Fisher Scientific, we offer a comprehensive range of ready-to-use tests and automation-compatible workflows to help you achieve your stringent quality standards, no matter the starting material. Streamline your current workflow with our analytical solutions to meet quality and purity standards.
Re-imagine analytical solutions for your cell therapy workflows with Thermo Fisher Scientific
- Streamline rapid safety testing—help ensure quick and reliable safety assessments.
- Facilitate assay scale-up—efficiently expand assay capabilities.
- Enhance assay development and validation—help improve accuracy and consistency.
- Automated processes—deliver consistent, reliable results.
Automated analytical solutions for cell therapy workflows
CFR Part 21–compliant digital automation solutions
Gibco CTS Cellmation software offers digital automation for cell therapy manufacturing, by seamlessly connecting Thermo Fisher Scientific's modular instrumentation. Its open platform allows flexible management and integration of multiple instruments, streamlining workflows and helping ensure 21 CFR Part 11/Annex 11 compliance. Powered by DeltaV Distributed Control System (DCS) and developed using GAMP5 methods, CTS Cellmation Software helps ensure compatibility with cGMP-compliant processes. It is designed to scale effortlessly from process development to clinical manufacturing and commercialization.
Discover educational resources for cell therapy manufacturing
Access educational resources and learning materials to streamline your cell therapy manufacturing workflows. Explore our extensive content to make the most of your time, effort, and clinical outcomes.
Blog:Guide to cell therapy GMP manufacturing for autologous CAR-T
Read this blog to explore the benefits of autologous cell therapy, reduced immune rejection, and GMP-compliant process automation advancements for improved patient access and manufacturing.
Cell therapy brochure
Discover a comprehensive catalog of instruments, media, and reagents for cell therapy manufacturers, offering quality products and scalable solutions to advance your therapy from discovery to clinic.
Cell therapy handbook
Explore the Cell Therapy Handbook for essential methodologies, practices, and resources to support and enhance your cell therapy manufacturing workflow, whether you're new or expanding your knowledge.
New publication: Enhancing CAR-T cell therapy manufacturing efficiency through semi-automated bioprocessing
Discover how automated CAR-T cell manufacturing using CTS Cellmation software can overcome manual production challenges, improving efficiency, product quality, and data management for timely patient treatment.
Learn more
Exploring automation and flexible cell therapy manufacturing
Read this article to discover how next-gen cell therapy manufacturing leverages flexibility and automation to address capacity challenges and enhance global patient access to advanced treatments.
24-hour CAR-T process
Learn about a new 24-hour CAR T manufacturing process leveraging digital integration and CTS Detachable Dynabeads CD3/CD28, with insights on reducing costs, shortening timelines, and overcoming challenges in this on-demand webinar.
Style Sheet for Global Design System
Stylesheet for Classic Wide Template adjustments